Literature DB >> 28983659

Cardiac and peripheral vasomotor autonomic functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy.

Haruki Koike1, Tomohiko Nakamura2, Atsushi Hashizume2, Ryoji Nishi2, Shohei Ikeda2, Yuichi Kawagashira2, Masahiro Iijima2, Masahisa Katsuno2, Gen Sobue3,4.   

Abstract

The objective of this study was to systematically investigate cardiac and peripheral vasomotor autonomic functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy (FAP ATTR Val30Met) patients from non-endemic areas. The coefficient of variation of R-R intervals (CVR-R), responses to the Valsalva manoeuvre, head-up tilt test with impedance cardiography, noradrenaline infusion test, and (123)I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy were assessed in eight patients. Although only four patients manifested orthostatic hypotension during the head-up tilt test, CVR-R, responses to the Valsalva manoeuvre, and myocardial MIBG uptake indicated a higher prevalence of cardiac sympathetic and parasympathetic dysfunction. Total peripheral resistance at 60° tilt did not increase from baseline values in five of six examined patients. An infusion of low-dose noradrenaline induced an increase in systolic blood pressure in all patients. The extent of the change in systolic blood pressure negatively correlated to that in total peripheral resistance (p < 0.05). Patients with poor vasoconstrictor responses to orthostatic stress tended to exhibit severe reduction of unmyelinated fibres in sural nerve biopsy specimens. In conclusion, both cardiac and peripheral vasomotor autonomic dysfunctions were prevalent in late-onset FAP ATTR Val30Met patients from non-endemic areas, even in those without orthostatic intolerance. However, vasoconstriction by alpha-adrenoceptor agonists was preserved even after denervation, carrying important implications for the management of orthostatic hypotension in FAP.

Entities:  

Keywords:  Amyloid; Amyloidosis; Familial amyloid polyneuropathy; Resistance vessels; Transthyretin

Mesh:

Substances:

Year:  2017        PMID: 28983659     DOI: 10.1007/s00415-017-8629-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  39 in total

1.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

Review 2.  Association of leptin with orthostatic blood pressure changes in Parkinson's disease.

Authors:  Tomohiko Nakamura; Masashi Suzuki; Akinori Okada; Junichiro Suzuki; Satoru Hasegawa; Haruki Koike; Masaaki Hirayama; Masahisa Katsuno; Gen Sobue
Journal:  Mov Disord       Date:  2016-06-06       Impact factor: 10.338

Review 3.  Transthyretin-related familial amyloidotic polyneuropathy.

Authors:  Yukio Ando; Masaaki Nakamura; Shukuro Araki
Journal:  Arch Neurol       Date:  2005-07

4.  Radiolabelled meta-iodobenzylguanidine in assessment of autonomic dysfunction.

Authors:  Y Ando; K Obayashi; Y Tanaka; T Tsuji; M Uchino; M Takahashi; M Ando
Journal:  Lancet       Date:  1994-04-16       Impact factor: 79.321

5.  Myocardial muscarinic receptor upregulation and normal response to isoproterenol in denervated hearts by familial amyloid polyneuropathy.

Authors:  N Delahaye; D Le Guludec; S Dinanian; J Delforge; M S Slama; L Sarda; F Dollé; H Mzabi; D Samuel; D Adams; A Syrota; P Merlet
Journal:  Circulation       Date:  2001-12-11       Impact factor: 29.690

6.  Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form.

Authors:  Haruki Koike; Ken-ichiro Misu; Shu-ichi Ikeda; Yukio Ando; Masamitsu Nakazato; Eiko Ando; Masahiko Yamamoto; Naoki Hattori; Gen Sobue
Journal:  Arch Neurol       Date:  2002-11

7.  Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis.

Authors:  Haruki Koike; Rina Hashimoto; Minoru Tomita; Yuichi Kawagashira; Masahiro Iijima; Fumiaki Tanaka; Gen Sobue
Journal:  Amyloid       Date:  2011-04-05       Impact factor: 7.141

8.  Role of cardiac sympathetic nerves in preventing orthostatic hypotension in Parkinson's disease.

Authors:  Tomohiko Nakamura; Masaaki Hirayama; Takashi Hara; Yasuaki Mizutani; Junichiro Suzuki; Hirohisa Watanabe; Gen Sobue
Journal:  Parkinsonism Relat Disord       Date:  2014-01-14       Impact factor: 4.891

9.  Potential Role of In Vivo Confocal Microscopy for Imaging Corneal Nerves in Transthyretin Familial Amyloid Polyneuropathy.

Authors:  Antoine Rousseau; Cecile Cauquil; Benedicte Dupas; Antoine Labbé; Christophe Baudouin; Emmanuel Barreau; Marie Théaudin; Catherine Lacroix; Anne Guiochon-Mantel; Anouar Benmalek; Marc Labetoulle; David Adams
Journal:  JAMA Ophthalmol       Date:  2016-09-01       Impact factor: 7.389

10.  Sudomotor innervation in transthyretin amyloid neuropathy: Pathology and functional correlates.

Authors:  Chi-Chao Chao; Cho-Min Huang; Hao-Hua Chiang; Kai-Ren Luo; Hung-Wei Kan; Naomi Chu-Chiao Yang; Hao Chiang; Whei-Min Lin; Shu-Mei Lai; Ming-Jen Lee; Chia-Tung Shun; Sung-Tsang Hsieh
Journal:  Ann Neurol       Date:  2015-07-01       Impact factor: 10.422

View more
  6 in total

Review 1.  Multidisciplinary Approaches for Transthyretin Amyloidosis.

Authors:  Haruki Koike; Takahiro Okumura; Toyoaki Murohara; Masahisa Katsuno
Journal:  Cardiol Ther       Date:  2021-06-04

2.  Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management.

Authors:  Jose-Alberto Palma; Alejandra Gonzalez-Duarte; Horacio Kaufmann
Journal:  Clin Auton Res       Date:  2019-08-26       Impact factor: 4.435

Review 3.  Novel RNA-targeted therapies for hereditary ATTR amyloidosis and their impact on the autonomic nervous system.

Authors:  Isabel Conceição
Journal:  Clin Auton Res       Date:  2019-08-09       Impact factor: 4.435

4.  Expert opinion on monitoring symptomatic hereditary transthyretin-mediated amyloidosis and assessment of disease progression.

Authors:  David Adams; Vincent Algalarrondo; Michael Polydefkis; Nitasha Sarswat; Michel S Slama; Jose Nativi-Nicolau
Journal:  Orphanet J Rare Dis       Date:  2021-10-03       Impact factor: 4.123

Review 5.  Multimodality Imaging in the Evaluation and Management of Cardiac Amyloidosis.

Authors:  Yiu Ming Khor; Sarah Cuddy; Rodney H Falk; Sharmila Dorbala
Journal:  Semin Nucl Med       Date:  2020-02-09       Impact factor: 4.802

6.  Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan.

Authors:  Zenshi Miyake; Kiyotaka Nakamagoe; Naoki Ezawa; Tsuneaki Yoshinaga; Ryosuke Hashimoto; Taiki Sato; Yoshiki Sekijima; Akira Tamaoka
Journal:  Intern Med       Date:  2018-10-17       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.